Report Library
All Reports
Podcast: ADA Wrap-Up
June 28, 2017
The 2017 annual Scientific Sessions of the American Diabetes Association (ADA) was held in San Diego from June 9-13, 2017. This audio
only podcast features Informa Pharma Intelligence analysts Dr. Peter Chang (Biomedtracker), Kevin Shannon (Datamonitor Healthcare),
and Jake Mathon (Citeline) as they discuss their initial impressions of the meeting. Podcast topics include:
- SGLT-2 Inhibitors
- Invokana's CANVAS (JNJ, DSKYF, Mitsubishi)
- Sotagliflozin (SNY, LXRX)
- Ertugliflozin (MRK, PFE)
- Fixed Dose Combinations
- GLP-1 Agonists
- Victoza's LEADER Adcom (NVO)
- Semaglutide and retinopathy (NVO)
- Insulins
- Tresiba's DEVOTE (NVO)
- Biosimilar Glargine (MRK, MYL/Biocon, Gan & Lee)
- LY900014 (LLY)
| Indications Covered: |
Acute Coronary Syndrome (ACS)
Chronic Heart Failure - Reduced Ejection Fraction (Chronic HFrEF) Coronary Artery Disease Diabetes Mellitus, Type I Diabetes Mellitus, Type II Diabetic Nephropathy Ischemic Stroke Obesity |
Additional Resources: